semaglutide compounding fda enforcement news The growing availability of compounded GLP-1 weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. Link in comments⬇️ FDA's GLP-1 decision kicks off

Reactive oxygen species: do they play a role in adaptive immunity

Many M.C., Mestdagh C., Van Den Hove M.F., Denef J.F

More cautious dosing and closer self-monitoring make sense for older users

Persistence remains mixed: a 2024 real-world study found 32% on therapy at 1 year among non-diabetic users, and according to Prime Therapeutics, only 1 in 12 remain at 3 years

Individual responses to medications vary, and treatment decisions should always be made in consultation with a qualified medical professional who is aware of your complete medical history

Black, Hispanic, American Indian and Alaska Native, and Native Hawaiian and Pacific Islander adults have higher per capita obesity rates than white adults, they are less likely to have health insurance and more likely to have lower incomes, according to a 2023 analysis from KFF